Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer
Status:
Completed
Trial end date:
2000-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug with peripheral stem cell
transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more
tumor cells.
PURPOSE: Phase II trial to study the effectiveness of high dose chemotherapy plus peripheral
stem cell transplantation followed by combination chemotherapy in treating patients with
metastatic prostate cancer that has not responded to hormone therapy.
Phase:
Phase 2
Details
Lead Sponsor:
University of Maryland Greenebaum Cancer Center University of Maryland, Baltimore